Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Licensing revenue	$ 850	$ 0	$ 850	$ 0
Research and development	11,174	10,223	20,695	16,862
General and administrative	4,721	3,114	7,969	6,183
Total operating expenses	15,895	13,337	28,664	23,045
Loss from operations	(15,045)	(13,337)	(27,814)	(23,045)
Other income	1,969	2,059	3,951	3,930
Loss before income tax expense	(13,076)	(11,278)	(23,863)	(19,115)
Income tax expense	0	0	0	0
Net loss	$ (13,076)	$ (11,278)	$ (23,863)	$ (19,115)
Net loss per share - basic and diluted (in dollars per share)	$ (0.1)	$ (0.09)	$ (0.17)	$ (0.15)
Basic and diluted weighted average shares outstanding (in shares)	137,589	126,729	137,098	126,539
Other comprehensive loss:
Net loss	$ (13,076)	$ (11,278)	$ (23,863)	$ (19,115)
Unrealized loss on marketable securities	(1)	(361)	(128)	(205)
Comprehensive loss	$ (13,077)	$ (11,639)	$ (23,991)	$ (19,320)